Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | APP | P05067 | 2/20 | 0.48 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 5/20 | 0.46 |
| ▸ | CA2 | P00918 | 5/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL9505045 | 0.86 | TDP1 (0.73) | TDP1MAPK1ALDH1A1CYP3A4APP | |
| Sulfuric Acid SCHEMBL7630477 | 0.86 | TDP1 (0.73) | TDP1MAPK1ALDH1A1CYP3A4APP | |
| Mequinol SCHEMBL8898999 | 0.83 | PKM (0.61) | ALDH1A1APPCA1CA2CA9 | |
| SCHEMBL22462568 | 0.82 | TDP1 (0.73) | TDP1MAPK1ALDH1A1CYP3A4APP | |
| Trifluoromethanesulfonic Acid SCHEMBL27825973 | 0.81 | CA1 (0.46) | ALDH1A1CA1CA2CA9HSD11B1 | |
| Trifluoromethanesulfonic Acid SCHEMBL18306126 | 0.81 | APP (0.44) | ALDH1A1APPCA1CA2CA9 | |
| Trifluoromethanesulfonic Acid SCHEMBL1859837 | 0.81 | APP (0.44) | ALDH1A1APPCA1CA2CA9 | |
| Trifluoromethanesulfonic Acid SCHEMBL3385544 | 0.81 | HSD11B1 (0.44) | ALDH1A1CA1CA2CA9HSD11B1 | |
| Anisole SCHEMBL4551224 | 0.81 | CA4 (0.56) | CA1CA2HSD11B1PKMGAA | |
| Trifluoromethanesulfonic Acid SCHEMBL28499316 | 0.81 | MAOB (0.51) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107513015-B | Method for preparing 3-benzoyl ethyl acrylate from enalapril intermediate synthesis mother liquor | 浙江工业大学 | 2020-11-06 | — | — | CN | claimed |
| US-7351849-B2 | Process for producing optically active β-amino acid derivatives | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-04-01 | — | — | US | disclosed |
| US-20060205968-A1 | Process for producing optically active beta-amino acid derivatives | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-09-14 | — | — | US | disclosed |
| EP-1656342-A2 | PROCESS FOR PRODUCING OPTICALLY ACTIVE BETA-AMINO ACID DERIVATIVES | Takasago International Corporation (JP) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005016866-A2 | PROCESS FOR PRODUCING OPTICALLY ACTIIVE BETA-AMINO ACID DERIVATIVES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205968-A1 | Process for producing optically active beta-amino acid derivatives | BCAT1, ALAD, AADAT | TDP1 4754/4885MAPK1 838/4885ALDH1A1 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.